United Kingdom

350,806 series

SeriesLocationUnitFrequencyLatestSource
United Kingdom exports to India · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Singapore · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Slovenia · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Spain · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Sweden · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Switzerland · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Brazil · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Thailand · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Türkiye · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Egypt · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to USA · Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its saltsUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to France · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Germany · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Ireland · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Japan · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Netherlands · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to India · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Spain · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Switzerland · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to USA · Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fusedUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Germany · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, malonylurea (barbituric acid) and its derivatives: salts thereofUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Ireland · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, malonylurea (barbituric acid) and its derivatives: salts thereofUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Canada · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to China · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Denmark · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Finland · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to France · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Germany · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Greece · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Argentina · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Hungary · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Australia · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Ireland · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Israel · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Italy · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Japan · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Austria · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Rep. of Korea · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Other Asia, nes · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Netherlands · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to New Zealand · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to India · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Singapore · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Slovenia · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Spain · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Sweden · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Switzerland · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Brazil · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Türkiye · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to USA · Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nucleic acids and their salts, excluding malonylureaUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Ireland · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Canada · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to China · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to France · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Germany · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to China, Hong Kong SAR · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Australia · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Ireland · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Austria · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Netherlands · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Norway · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to India · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Spain · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Sweden · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Switzerland · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Türkiye · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to USA · Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamineUnited KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Canada · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to France · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Germany · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Ireland · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Italy · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Japan · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Netherlands · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Singapore · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Sweden · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Switzerland · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to USA · Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam)United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Canada · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Chile · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to China · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Colombia · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Croatia · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Czechia · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Denmark · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Finland · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to France · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Germany · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Greece · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Argentina · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to China, Hong Kong SAR · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Hungary · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Australia · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Indonesia · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Ireland · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Israel · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Italy · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Japan · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Austria · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom exports to Kenya · Heterocyclic compounds: n.e.s. in heading no. 2933United KingdomUSDAnnual2024-01-01CEPII
United Kingdom: prices and trade data | Codefact Research Data